Use of biologics for psoriasis in solid organ transplant recipients
We report a case from our institution of a 29-year-old man with a history of psoriasis, who underwent a kidney transplant and later developed erythroderma. He did not respond to traditional treatments and was successfully treated with adalimumab, leading to the discontinuation of MMF. We also reviewed literature in solid organ transplant patients with psoriasis. Our findings, based on 10 articles, indicate a cautious approach to using biologics in this group, with further research needed for efficacy and safety.PMID:38623950 | DOI:10.1111/ajd.14292
Source: The Australasian Journal of Dermatology - Category: Dermatology Authors: Marta Costa Blasco Claire Doyle Sophie Diong Siona Ni Raghallaigh Source Type: research
More News: Dermatology | Humira | Kidney Transplant | Kidney Transplantation | Psoriasis | Skin | Study | Transplant Surgery | Transplants | Urology & Nephrology